Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
2024 November
  • Home
  • Archive for November, 2024
A conversation with a genius lightbulb

Ross Youngs “A conversation with a genius”

  • November 27 2024

By Ross Youngs, November 27, 2024 “A conversation with a genius” Key points: The bottleneck in drug discovery suggests we need 1,000,000,000,000,000,000,000,000,000 years or more. Even with generous assumptions and the full force of global computing power, creating and testing all possible drug-like molecules within a reasonable timeframe remains a distant prospect. However, this thought experiment

Continue Reading

Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact

  • November 12 2024

Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact (November 12, 2024) by Nick Paul Taylor. ovartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs and identify

Continue Reading

RSS Industry News

  • Gut microbial ammonia enhances colonic acetylcholine levels to regulate intestinal motility February 20 2026
  • Setting higher standards for reports of microbial species in human cancers February 19 2026
  • Potential biomarkers for early periodontal inflammation: investigating CD5+ B cells, salivary cytokines and oral microbiome February 18 2026
  • Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infection February 16 2026
  • Microbiome-mediated colonization resistance to and countermeasures of Klebsiella pneumoniae February 16 2026
  • Author Correction: Formononetin derived from Parabacteroides merdae alleviates MPTP-induced Parkinson’s disease in mice by inhibiting ferroptosis via the PI3K-AKT-ferritinophagy axis February 16 2026
  • Babies at nursery shape each other’s microbiomes February 11 2026
  • Convergent extreme reductive evolution in ancient planthopper symbioses February 7 2026
  • Microbiota-derived IPA protects against colitis by regulating intestinal HMGCS2-mediated ketogenesis to facilitate mucosal healing February 6 2026
  • Host factors dictate gut microbiome alterations in chronic kidney disease more strongly than kidney function February 5 2026
Quick Link
  • Products & Services
  • Blog
  • Contact
Recent Posts
  • AI, Microbiomes, & 8 Orders of Magnitude Improvement
  • Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo
  • The Billion Dollar Savings per Approved Drug
Sign up for our newsletter
Loading
Biosortia Microbiomics © 2026. All Rights Reserved.